Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Name: Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight
Published: 2017
License: Public Domain

Bayer · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

clinical pharmacology

pharmacology, clinical, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents